Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online May 1, 2007
Diabetes 56:2242-2250, 2007
DOI: 10.2337/db07-0425
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-0425v1
56/9/2242    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inouye, K. E.
Right arrow Articles by Flier, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inouye, K. E.
Right arrow Articles by Flier, J. S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Absence of CC Chemokine Ligand 2 Does Not Limit Obesity-Associated Infiltration of Macrophages Into Adipose Tissue

Karen E. Inouye1, Hang Shi1, Jane K. Howard1, Christine H. Daly2, Graham M. Lord3, Barrett J. Rollins2, and Jeffrey S. Flier1

1 Department of Medicine, Division of Endocrinology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
2 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
3 Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts

Address correspondence and eprint requests to Jeffrey S. Flier, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Finard 202, Boston, MA 02215. E-mail: jflier{at}bidmc.harvard.edu

Abbreviations: CCL, CC chemokine ligand; CCR, CC chemokine receptor; FACS, fluorescence-activated cell sorting; HIF-1{alpha}, hypoxia-inducible factor-1{alpha}; IL, interleukin; iNOS, inducible nitric oxide synthase; ITT, insulin tolerance test; KRH, Krebs-Ringer HEPES; MCP, monocyte chemoattractant protein; SOCS-3, suppressor of cytokine signaling-3; TNF-{alpha}, tumor necrosis factor-{alpha}

Macrophage recruitment to adipose tissue in obesity contributes to enhanced adipose tissue inflammatory activity and thus may underlie obesity-associated metabolic dysfunction. Obese adipose tissue exhibits increases in CC chemokine ligand 2 (CCL2, or monocyte chemoattractant protein-1), an important macrophage-recruiting factor. We therefore hypothesized that elevated CCL2 may contribute to obesity-associated adipose tissue macrophage recruitment. Male 6-week-old CCL2–/– and wild-type mice (n = 11–14 per group) were fed standard and high-fat diets until 34 weeks of age. At 12–16 and 25–29 weeks of age, blood was collected for plasma glucose and hormone measurements, and glucose tolerance and insulin tolerance tests were performed. Adipose tissue was collected at 34 weeks for analysis of macrophage infiltration. Surprisingly, CCL2–/– mice on high-fat diet showed no reductions in adipose tissue macrophages. CCL2–/– mice on standard and high-fat diet were also glucose intolerant and had mildly increased plasma glucose and decreased serum adiponectin levels compared with wild-type mice. On high-fat diet, CCL2–/– mice also gained slightly more weight and were hyperinsulinemic compared with wild-type mice. Because macrophage levels were unchanged in CCL2–/– mice, the phenotype appears to be caused by lack of CCL2 itself. The fact that metabolic function was altered in CCL2–/– mice, despite no changes in adipose tissue macrophage levels, suggests that CCL2 has effects on metabolism that are independent of its macrophage-recruiting capabilities. Importantly, we conclude that CCL2 is not critical for adipose tissue macrophage recruitment. The dominant factor for recruiting macrophages in adipose tissue during obesity therefore remains to be identified.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
E. A. Kirk, Z. K. Sagawa, T. O. McDonald, K. D. O'Brien, and J. W. Heinecke
Macrophage Chemoattractant Protein-1 Deficiency Fails to Restrain Macrophage Infiltration Into Adipose Tissue
Diabetes, May 1, 2008; 57(5): 1254 - 1261.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. J. Strissel, Z. Stancheva, H. Miyoshi, J. W. Perfield II, J. DeFuria, Z. Jick, A. S. Greenberg, and M. S. Obin
Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications
Diabetes, December 1, 2007; 56(12): 2910 - 2918.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.